TY - JOUR
T1 - Comparison of Single-Port Robotic Donor Nephrectomy and Laparoscopic Donor Nephrectomy
AU - Palese, Michael A.
AU - Chin, Chih Peng
AU - Garden, Evan B.
AU - Eilender, Benjamin
AU - Levy, Micah
AU - Ravivarapu, Krishna T.
AU - Wang, Daniel
AU - Freid, Hannah
AU - Al-Alao, Osama
AU - Araya, Joseph Sewell
AU - LaPointe-Rudow, Dianne
AU - Herron, Daniel
AU - Chin, Edward
AU - Arvelakis, Antonios
AU - Shapiro, Ron
AU - Larenas, Francisca
AU - Florman, Sander S.
N1 - Publisher Copyright:
© 2024 Mary Ann Liebert Inc.. All rights reserved.
PY - 2024/2/1
Y1 - 2024/2/1
N2 - Purpose: To compare the intra- and postoperative outcomes of single-port robotic donor nephrectomies (SP RDNs) and laparoscopic donor nephrectomies (LDNs). Materials and Methods: We retrospectively reviewed our institutional database for patients who received LDN or SP RDN between September 2020 and December 2022. Donor baseline characteristics, intraoperative outcomes, postoperative outcomes, and recipient renal function were extracted and compared between LDN and SP RDN. SP RDN learning curve analysis based on operative time and graft extraction time was performed using cumulative sum analysis. Results: One hundred forty-four patients underwent LDN and 32 patients underwent SP RDN. LDN and SP RDN had similar operative times (LDN: 190.3 - 28.0 minutes, SP RDN: 194.5 - 35.1 minutes, p = 0.3253). SP RDN patients had significantly greater extraction times (LDN: 83.2 - 40.3 seconds, SP RDN: 204.1 - 52.2 seconds, p < 0.0001) and warm ischemia times (LDN: 145.1 - 61.7 seconds, SP RDN: 275.4 - 65.6 seconds, p < 0.0001). There were no differences in patient subjective pain scores, inpatient opioid usage, or Clavien- Dindo II+ complications. Short- and medium-term postoperative donor and recipient renal function were also similar between the groups. SP RDN graft extraction time and total operative time learning curves were achieved at case 27 and 13, respectively. Conclusion: SP RDN is a safe and feasible alternative to LDN that minimizes postoperative abdominal incisional scars and has a short learning curve. Future randomized prospective clinical trials are needed to confirm the findings of this study and to identify other potential benefits and drawbacks of SP RDNs.
AB - Purpose: To compare the intra- and postoperative outcomes of single-port robotic donor nephrectomies (SP RDNs) and laparoscopic donor nephrectomies (LDNs). Materials and Methods: We retrospectively reviewed our institutional database for patients who received LDN or SP RDN between September 2020 and December 2022. Donor baseline characteristics, intraoperative outcomes, postoperative outcomes, and recipient renal function were extracted and compared between LDN and SP RDN. SP RDN learning curve analysis based on operative time and graft extraction time was performed using cumulative sum analysis. Results: One hundred forty-four patients underwent LDN and 32 patients underwent SP RDN. LDN and SP RDN had similar operative times (LDN: 190.3 - 28.0 minutes, SP RDN: 194.5 - 35.1 minutes, p = 0.3253). SP RDN patients had significantly greater extraction times (LDN: 83.2 - 40.3 seconds, SP RDN: 204.1 - 52.2 seconds, p < 0.0001) and warm ischemia times (LDN: 145.1 - 61.7 seconds, SP RDN: 275.4 - 65.6 seconds, p < 0.0001). There were no differences in patient subjective pain scores, inpatient opioid usage, or Clavien- Dindo II+ complications. Short- and medium-term postoperative donor and recipient renal function were also similar between the groups. SP RDN graft extraction time and total operative time learning curves were achieved at case 27 and 13, respectively. Conclusion: SP RDN is a safe and feasible alternative to LDN that minimizes postoperative abdominal incisional scars and has a short learning curve. Future randomized prospective clinical trials are needed to confirm the findings of this study and to identify other potential benefits and drawbacks of SP RDNs.
KW - laparoscopy approach
KW - renal transplant or donor nephrectomy
KW - robotics
UR - http://www.scopus.com/inward/record.url?scp=85185845378&partnerID=8YFLogxK
U2 - 10.1089/end.2023.0364
DO - 10.1089/end.2023.0364
M3 - Article
C2 - 38185847
AN - SCOPUS:85185845378
SN - 0892-7790
VL - 38
SP - 136
EP - 141
JO - Journal of Endourology
JF - Journal of Endourology
IS - 2
ER -